Zum Inhalt springen

Investor Update

Basel 9 November 2009

Anti-Malignancy Agent Avastin Obtained Approval for Additional Indication of Non-Small Cell Lung Cancer

Dear Investor,
Please find attached a press release issued by Chugai in Japan

See attached press release